يعرض 61 - 80 نتائج من 3,068 نتيجة بحث عن '(( decrease ((heat resistance) OR (host resistance)) ) OR ( decrease tumor resistance ))*', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65

    Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

    منشور في 2025
    "…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …"
  6. 66
  7. 67

    DataSheet_1_Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.zip حسب Ivan J. Cohen (5783102)

    منشور في 2022
    "…Patients whose tumors are resistant to immunotherapy often lack high levels of pre-existing inflammation in the tumor microenvironment. …"
  8. 68

    DataSheet_2_Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.zip حسب Ivan J. Cohen (5783102)

    منشور في 2022
    "…Patients whose tumors are resistant to immunotherapy often lack high levels of pre-existing inflammation in the tumor microenvironment. …"
  9. 69

    Image_1_Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling.TIF حسب Lan Yin (131556)

    منشور في 2021
    "…<p>Ovarian cancer is the most lethal gynaecologic tumor, with which multi-drug resistance as the major therapeutic hindrance. …"
  10. 70

    Image_2_Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling.TIF حسب Lan Yin (131556)

    منشور في 2021
    "…<p>Ovarian cancer is the most lethal gynaecologic tumor, with which multi-drug resistance as the major therapeutic hindrance. …"
  11. 71

    Image_3_Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling.TIF حسب Lan Yin (131556)

    منشور في 2021
    "…<p>Ovarian cancer is the most lethal gynaecologic tumor, with which multi-drug resistance as the major therapeutic hindrance. …"
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80